Zur Person

Van Belle S, Karanikiotis C, Labourey JL, Galid A, Wheeler T, Pujol B.
Curr Med Res Opin. 2011 May;27(5):987-94. Epub 2011 Mar 9.

Current practice of darbepoetin alfa in the management of haemoglobin levels in cancer patients undergoing chemotherapy - data from the CHOICE study.

Steger GG, Galid A, Gnant M, Mlineritsch B, Lang A, Tausch C, Rudas M, Greil R, Wenzel C, Singer CF, Haid A, Pöstlberger S, Samonigg H, Luschin-Ebengreuth G, Kwasny W, Klug E, Kubista E, Menzel C, Jakesz R; ABCSG-14.

Pathologic complete response with six compared with three cycles of neoadjuvant epirubicin plus docetaxel and granulocyte colony-stimulating factor in operable breast cancer: results of ABCSG-14.
J Clin Oncol. 2007 May 20;25(15):2012-8.

Gnant MF, Mlineritsch B, Luschin-Ebengreuth G, Grampp S, Kaessmann H, Schmid M, Menzel C, Piswanger-Soelkner JC, Galid A, Mittlboeck M, Hausmaninger H, Jakesz R; Austrian Breast and Colorectal Cancer Study Group.

Zoledronic acid prevents cancer treatment-induced bone loss in premenopausal women receiving adjuvant endocrine therapy for hormone-responsive breast cancer: a report from the Austrian Breast and Colorectal Cancer Study Group.
J Clin Oncol. 2007 Mar 1;25(7):820-8. Epub 2006 Dec 11.

Memarsadeghi M, Riedl CC, Kaneider A, Galid A, Rudas M, Matzek W, Helbich TH.

Axillary lymph node metastases in patients with breast carcinomas: assessment with nonenhanced versus uspio-enhanced MR imaging.
Radiology. 2006 Nov;241(2):367-77.

Riener EK, Hefler LA, Grimm C, Galid A, Zeillinger R, Tong-Cacsire D, Gitsch G, Leodolter S, Tempfer CB.

Polymorphisms of the endothelial nitric oxide synthase gene in women with vulvar cancer.
Gynecol Oncol. 2004 Jun;93(3):686-90.

Singer CF, Hudelist G, Galid A, Kubista E.

Pharmacological modulation of local feedback mechanisms as a therapeutic approach in breast cancer treatment.
Drugs Today (Barc). 2003 Dec;39(12):917-26. Review.
PMID: 14747837 [PubMed - indexed for MEDLINE]

Galid A
Mammakarzinom – Daten zur Prävention
Gyn-Aktiv 2007

Galid A
Blinder Fleck Tumoranämie
Gyn-Aktiv 2006

Galid A
Präoperative Chemotherapie beim Mammakarzinom
Gyn-Aktiv 2004

Galid A
Preoperative Core Biopsy and ist influence on surgical specimen volume
ASCO 2004, New Orleans, Abstract

Galid A
Tamoxifen und sein Einfluss auf das Endometrium – eine Zusammenfassung.
ABCSG Newsletter 13, Juni 2003

Taucher S, Salat A, Gnant M, Kwasny W, Mlineritsch B, Menzel RC, Schmid M, Smola MG, Stierer M, Tausch C, Galid A, Steger G, Jakesz R; Austrian Breast and Colorectal Cancer Study Group.
Impact of pretreatment thrombocytosis on survival in primary breast cancer.
Thromb Haemost. 2003 Jun;89(6):1098-106.

Green MD, Koelbl H, Baselga J, Galid A, Guillem V, Gascon P, Siena S, Lalisang RI, Samonigg H, Clemens MR, Zani V, Liang B, Renwick J, Piccart MJ; International Pegfilgrastim 749 Study Group
A randomized double-blind multicenter phase III study of fixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapy.
Ann Oncol. 2003 Jan;14(1):29-35.

Seifert M, Galid A, Kubista E.
The oestrogen receptor and its selective modulators in gynaecological oncology.
Eur J Cancer. 2000 Sep;36 Suppl 4:S66-7.

Seifert M, Galid A, Kubista E.
Estrogen replacement therapy in women with a history of breast cancer.
Maturitas. 1999 Jun 21;32(2):63-8.

Seifert M, Galid A
Oral contraceptives and breast cancer--a causal relationship?
Gynakol Geburtshilfliche Rundsch. 1998;38(2):101-4.


OEGGG Österr. Ges. für Gynäkologie und Geburtshilfe
ÖGS Österr. Ges. für Senologie
ESIDOG Arbeitsgemeinschaft für Infektionen der Österreichischen Gesellschaft für Gynäkologie und Geburtshilfe
ASCO American Society for Clinical Oncology
Verein der Freunde des Brustzentrum Hanusch Krankenhaus
Reviewer European Journal of Surgical Oncology
Reviewer Journal Tumorboard
© 2008 www.schrittweise.at